Alprostapint

Recall | Medicines | 18/12/2015

The marketing authorization holder informed its supplied customers in a letter dated December 16, 2015, that a reduced active ingredient content was detected in the above batch in the course of routine stability tests, so that the shelf life until the stated expiry date is not guaranteed. The batch will therefore be exchanged for a replacement.

Name of the medicinal product Alprostapint 500 Mikrogramm - Konzentrat zur Infusionsbereitung
Marketing authorisation number(s) 1-21573
Marketing authorisation holder Gebro Pharma GmbH
Batch number(s) 143104AT
Classification of the recall2
BASG reference number INS - 640.001 - 1527
Email

Further inquiry note